Genome structure in the vole bacillus, Mycobacterium microti, a member of the Mycobacterium tuberculosis complex with a low virulence for humans

Microbiology

Volumn 150, Issue 5, 2004, Pages 1519-1527

  Frota, Cristiane C ^a,d   Hunt, Debbie M ^a   Buxton, Roger S ^a   Rickman, Lisa ^a,e   Hinds, Jason ^b   Kremer, Kristin ^c   van Soolingen, Dick ^c   Colston, M Joseph ^a  

^a Natl Institute for Medical Research   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; GENE DELETION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM MICROTI; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; VOLE;

MURIDAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM MICROTI; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 2942593902     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.26660-0     Document Type: Article

References (43)

1. Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Pane, S. & Small, P. M. (1999). Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284, 1520-1523.
2. Bloom, B. R. & Fine, P. E. (1994). The BCG experience: implications for future vaccines against tuberculosis. In Tuberculosis, Pathogenesis, Protection, and Control, pp. 531-557. Edited by B. R. Bloom. Washington, DC: American Society for Microbiology.
3. Brodin, P., Eilgmeier, K., Marmiesse, M., Bilault, A., Garnier, T., Niemann, S., Cole, S. T. & Brosch, R. (2002). Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. Infect Immun 70, 5568-5578.
4. Brooke, W. S. (1941). The vole acid-fast bacillus. Am Rev Tuberc 43, 806-816.
5. Brosch, R., Gordon, S. V., Pym, A., Eiglmeier, K., Garnier, T. & Cole, S. T. (2000). Comparative genomics of the mycobacteria. Int J Med Microbiol 290, 143-152.
6. Brosch, R., Gordon, S. V., Marmiesse, M. & 12 other authors (2002). A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 99, 3684-3689.
7. Cavanagh, R., Begon, M., Bennett, M. & 12 other authors (2002). Mycobacterium microti infection (vole tuberculosis) in wild rodent populations. J Clin Microbiol 40, 3281-3285.
8. Daffe, M. & Draper, P. (1998). The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39, 131-203.
9. Dannenberg, A. M., Bishai, W. R., Parrish, N., Ruiz, R., Johnson, W., Zook, B. C., Boles, J. W. & Pitt, L. M. (2000). Efficacies of BCG and vole bacillus (Mycobacterium microti) vaccines in preventing clinically apparent pulmonary tuberculosis in rabbits: a preliminary report. Vaccine 19, 796-800.
10. Davidson, L. A., Draper, P. & Minnikin, D. E. (1982). Studies on the mycolic acids from the walls of Mycobacterium microti. J Gen Microbiol 128, 823-828.
11. Eisen, M. B. & Brown, P. O. (1999). DNA arrays for analysis of gene expression. Methods Enzymol 303, 179-205.
12. Foudraine, N. A., van Soolingen, D., Noordhoek, G. T. & Reiss, P. (1998). Pulmonary tuberculosis due to Mycobacterium microti in a human immunodeficiency virus-infected patient. Clin Infect Dis 27, 1543-1544.
13. Gey van Pittius, N. C., Gamieldien, J., Hide, W., Brown, G. D., Siezen, R. J. & Beyers, A. D. (2001). The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. http://www.genomebiology.com/2001/2/10/research/0044.
14. Gomez, A., Mve-Obiang, A., Vray, B., Rudnicka, W., Shamputa, I. C., Portaels, F., Meyers, W. M., Fonteyne, P. A. & Realini, L. (2001). Detection of phospholipase C in nontuberculous mycobacteria and its possible role in hemolytic activity. J Clin Microbiol 39, 1396-1401.
15. Gordon, S. V., Brosch, R., Billault, A., Garnier, T., Eiglmeier, K. & Cole, S. T. (1999). Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32, 643-655.
16. Hart, P. D. & Sutherland, I. (1977). BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. BMJ 2 (6082), 293-295.
17. Horstkotte, M. A., Sobottka, I., Schewe, C. K., Schafer, P., Laufs, R., Rusch-Gerdes, S. & Niemann, S. (2001). Mycobacterium microti llama-type infection presenting as pulmonary tuberculosis in a human immunodeficiency virus-positive patient. J Clin Microbiol 39, 406-407.
18. Hsu, T., Hingley-Wilson, S. M., Chen, B. & 14 other authors (2003). The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A 100, 12420-12425.
19. Huitema, H. & Jaartsveld, F.H. (1967). Mycobacterium microti infection in a cat and some pigs. Antonie Van Leeuwenhoek 33, 209-212.
20. Johansen, K. A., Gill, R. E. & Vasin, M. L. (1996). Biochemical and molecular analysis of phospholipase C and phospholipase D activity in mycobacteria. Infect Immun 64, 3259-3266.
21. Kato-Maeda, M., Rhee, J. T., Gingeras, T. R., Salamon, H., Drenkow, J., Smittipat, N. & Small, P. M. (2001). Comparing genomes within the species Mycobacterium tuberculosis. Genome Res 11, 547-554.
22. Kremer, K., van Soolingen, D., van Embden, J., Hughes, S., Inwald, J. & Hewinson, G. (1998). Mycobacterium microti: more widespread than previously thought. J Clin Microbiol 36, 2793-2794.
23. Kremer, L., Baulard, A. R. & Besra, G. S. (2000). Genetics of mycolic acid biosynthesis. In Molecular Genetics of Mycobacteria, pp. 173-190. Edited by G. F. Hatfull & W. R. Jacobs, Jr. Washington, DC: American Society for Microbiology.
24. Larsen, M. H. (2000). Some common methods in mycobacterial genetics. In Molecular Genetics of Mycobacteria, pp. 313-320. Edited by G. F. Hatfull & W. R. Jacobs, Jr. Washington, DC: American Society for Microbiology.
25. Levy-Frebault, V. & Portaels, F. (1992). Proposed minimal standards for the genus Mycobacterium and for the description of new slowly growing Mycobacterium spp. Int J Syst Bacteriol 42, 315-323.
26. Mahairas, G. G., Sabo, P. J., Hickey, M, J., Singh, D. C. & Stover, C. K. (1996). Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178, 1274-1282.
27. Manabe, Y. C Scott, C. P. & Bishai, W. R. (2002). Naturally attenuated, orally administered Mycobacterium microti as a tuberculosis vaccine is better than subcutaneous Mycobacterium bovis BCG. Infect Immun 70, 1566-1570.
28. Niemann, S., Richter, E., Dalugge-Tamm, H., Schlesinger, H., Graupner, D., Konigstein, B., Gurath, G., Greinert, U. & Rusch-Gerdes, S. (2000). Two cases of Mycobacterium microti derived tuberculosis in HIV-negative immunocompetent patients. Emerg Infect Dis 6, 539-542.
29. Pattyn, S. R., Portaels, F., Spanoghe, L. & Magos, J. (1970). Further studies on African strains of Mycobacterium tuberculosis: comparison with M. bovis and M. microti. Ann Soc Belg Med Trop 50, 211-227.
30. Pym, A. S., Brodin, P., Brosch, R., Huerre, M. & Cole, S. T. (2002). Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 46, 709-717.
31. Pym, A. S., Brodin, P., Majlessi, L. & 7 other authors (2003). Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9, 533-539.
32. Rastogi, N., Legrand, E. & Sola, C. (2001). The mycobacteria: an introduction to nomenclature and pathogenesis. Rev Sci Tech 20, 21-54.
33. Raynaud, C., Guilhot, C., Rauzier, J., Bordat, Y., Pelicic, V., Manganelli, R., Smith, I., Gicquel, B. & Jackson, M. (2002). Phospholipases C are involved in the virulence of Mycobacterium tuberculosis. Mol Microbiol 45, 203-217.
34. Renshaw, P. S., Panagiotidou, P., Whelan, A., Gordon, S. V., Hewinson, R. G., Williamson, R. A. & Carr, M. D. (2002). Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6.CFP-10 complex. Implications for pathogenesis and virulence. J Biol Chem 277, 21598-21603.
35. Stanley, S. A., Raghavan, S., Hwang, W. W. & Cox, J. S. (2003). Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A 100, 13001-13006.
36. Sula, L. & Radkovsky, I. (1976). Protective effects of M. microti vaccine against tuberculosis. J Hyg Epidemiol Microbiol Immunol 20, 1-6.
37. Tsukamura, M., Mizuno, S. & Toyama, H. (1985). Taxonomic studies on the Mycobacterium tuberculosis series. Microbiol Immunol 29, 285-299.
38. van Soolingen, D. (2001). Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Intern Med 249, 1-26.
39. van Soolingen, D., van der Zanden, A. G., de Haas, P. E. & 7 other authors (1998). Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol 36, 1840-1845.
40. Watanabe, M., Aoyagi, Y., Ridell, M. & Minnikin, D. E. (2001). Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 147, 1825-1837.
41. Wayne, L. G. & Kubica, G. P. (1986). The mycobacteria. In Bergey's Manual of Systematic Bacteriology, pp. 1435-1457. Edited by P. H. A. Sneath and others. Baltimore, MD: Williams & Wilkins.
42. Wells, A. Q. (1937). Tuberculosis in wild voles. Lancet 1, 1221.
43. Wilderman, P. J., Vasil, A. I., Johnson, Z. & Vasil, M. L. (2001). Genetic and biochemical analyses of a eukaryotic-like phospholipase D of Pseudomonas aeruginosa suggest horizontal acquisition and a role for persistence in a chronic pulmonary infection model. Mol Microbiol 39, 291-303.